Guardant Health and American Cancer Society Partner to Expand Cancer Screening Access and Improve Health Equity

The American Cancer Society and Guardant Health have partnered to expand cancer screening access and improve health equity. The partnership aims to boost screening efforts in communities with restricted access to preventive care, particularly in California, which trails the national average in cancer screening rates. Guardant Health will support the ACS's "I Love You, Get Screened" campaign, which delivers culturally relevant education and promotes digital tools on cancer.org.

The American Cancer Society (ACS) and Guardant Health have entered into a strategic partnership aimed at enhancing cancer screening access and promoting health equity, particularly in underserved communities. This collaboration, announced on August 4, 2025, focuses on boosting screening efforts in areas with limited access to preventive care, with a specific emphasis on California, which lags behind the national average in cancer screening rates [1].

Guardant Health, a leading precision oncology company, will support ACS's "I Love You, Get Screened" campaign, which has garnered over 313 million impressions in 2024 and delivers culturally relevant education to diverse communities, including Black/African American, Hispanic/Latino, and LGBTQ+ populations [1]. The partnership will also involve promoting digital tools on cancer.org, such as a locator tool that helps individuals find screening locations across the U.S. Additionally, Guardant Health will support community health interventions, including patient education, navigation to screening appointments, transportation support, and language access services [1].

The collaboration is timely, given the ongoing need to reduce cancer disparities. In 2025, an estimated 2,041,910 people in the U.S. are expected to be diagnosed with cancer, with over 600,000 lives anticipated to be lost due to the disease [1]. Despite significant progress in reducing cancer mortality, disparities in screening rates persist, particularly in California. Only 64% of California women aged 45 and older are up to date on screening mammograms, compared to 69% nationally, while colorectal cancer screening rates are lower, with 60% of eligible Californians screened compared to 62% nationwide [1].

Through this partnership, ACS and Guardant Health aim to accelerate the momentum in cancer screening and treatment, with a special focus on underserved communities. The collaboration will also support state coalition work to implement localized strategies that help increase screening rates and reduce disparities [1].

Guardant Health's support of the ACS's initiatives will be crucial in reaching more people with the information, tools, and services they need to take action for their health. The partnership underscores the commitment of both organizations to ensuring that everyone, regardless of race, ethnicity, income, or ZIP code, has access to convenient and timely cancer screening [1].

In 2025, ACS will engage communities across the nation through impactful campaigns aligned with key cancer awareness months, including cervical cancer awareness in January, colorectal in March, prostate in September, breast in October, and lung in November. These efforts will feature personal stories, local events, and trusted education to empower more people to get screened and take charge of their health [1].

References:
[1] https://www.morningstar.com/news/business-wire/20250804054617/american-cancer-society-and-guardant-health-partner-to-expand-cancer-screening-access-and-advance-health-equity
[2] https://www.businesswire.com/news/home/20250804054617/en/American-Cancer-Society-and-Guardant-Health-Partner-to-Expand-Cancer-Screening-Access-and-Advance-Health-Equity